(Q30453231)

21 June 2017

1 reference

title

Inflammation in nonalcoholic steatohepatitis (English)

1 reference

21 June 2017

0 references

0 references

R Christopher Harmon

1

1 reference

21 June 2017

Dina G Tiniakos

series ordinal

2

1 reference

21 June 2017

Curtis K Argo

series ordinal

3

1 reference

21 June 2017

publication date

1 April 2011

1 reference

Expert Review of Gastroenterology & Hepatology

21 June 2017

published in

1 reference

21 June 2017

volume

5

1 reference

21 June 2017

issue

2

1 reference

21 June 2017

page(s)

189-200

1 reference

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

21 June 2017

cites work

1 reference

Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study

21 January 2018

1 reference

Is NASH underdiagnosed among African Americans?

21 January 2018

1 reference

Ethnic differences in the prevalence of cryptogenic cirrhosis

21 January 2018

1 reference

The epidemiology of nonalcoholic fatty liver disease: a global perspective

21 January 2018

1 reference

Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients

21 January 2018

1 reference

Clinical features and natural history of nonalcoholic steatosis syndromes

21 January 2018

1 reference

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease

21 January 2018

1 reference

Heritability of nonalcoholic fatty liver disease

21 January 2018

1 reference

I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease

21 January 2018

1 reference

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

21 January 2018

1 reference

A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans

21 January 2018

1 reference

A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity.

21 January 2018

1 reference

A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis

21 January 2018

1 reference

Polymorphisms in the adiponutrin gene are associated with increased insulin secretion and obesity

21 January 2018

1 reference

Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease

21 January 2018

1 reference

Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance

21 January 2018

1 reference

The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease

21 January 2018

1 reference

Genetic and environmental susceptibility to non-alcoholic fatty liver disease

21 January 2018

1 reference

Nonalcoholic fatty liver disease

21 January 2018

1 reference

Etiopathogenesis of nonalcoholic steatohepatitis

21 January 2018

1 reference

Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites

21 January 2018

1 reference

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

21 January 2018

1 reference

Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis

21 January 2018

1 reference

Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease

21 January 2018

1 reference

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection

21 January 2018

1 reference

Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications

21 January 2018

1 reference

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

Liver fibrosis in overweight patients

21 January 2018

1 reference

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients

21 January 2018

1 reference

Pathologic features associated with fibrosis in nonalcoholic fatty liver disease.

21 January 2018

1 reference

Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis

21 January 2018

1 reference

Hepatic steatosis: innocent bystander or guilty party?

21 January 2018

1 reference

Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis

21 January 2018

1 reference

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

21 January 2018

1 reference

Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis

21 January 2018

1 reference

Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice

21 January 2018

1 reference

Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis

21 January 2018

1 reference

A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).

21 January 2018

1 reference

Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease

21 January 2018

1 reference

Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis

21 January 2018

1 reference

Dietary sucrose is essential to the development of liver injury in the methionine-choline-deficient model of steatohepatitis

21 January 2018

1 reference

Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction

21 January 2018

1 reference

Effects of dietary fructose on liver steatosis in overfed mule ducks

21 January 2018

1 reference

Fructose consumption as a risk factor for non-alcoholic fatty liver disease

21 January 2018

1 reference

A lipidomic analysis of nonalcoholic fatty liver disease.

21 January 2018

1 reference

The plasma lipidomic signature of nonalcoholic steatohepatitis

21 January 2018

1 reference

Adipose tissue as an endocrine organ

21 January 2018

1 reference

Do regional differences in adipocyte biology provide new pathophysiological insights?

21 January 2018

1 reference

Visceral fat dominant distribution in male type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body type

21 January 2018

1 reference

Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans

21 January 2018

1 reference

Differences in adiponectin protein expression: effect of fat depots and type 2 diabetic status

21 January 2018

1 reference

21 January 2018

1 reference

The effect of pioglitazone on the liver: role of adiponectin.

21 January 2018

1 reference

The role of cytokines in non-alcoholic fatty liver disease

21 January 2018

1 reference

Enhanced metabolic flexibility associated with elevated adiponectin levels

21 January 2018

1 reference

Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone

21 January 2018

1 reference

Effects of troglitazone on fat distribution in the treatment of male type 2 diabetes.

21 January 2018

1 reference

Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes

21 January 2018

1 reference

Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients

21 January 2018

1 reference

Pioglitazone in the treatment of NASH: the role of adiponectin

21 January 2018

1 reference

High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis.

21 January 2018

1 reference

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

21 January 2018

1 reference

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

21 January 2018

1 reference

Genetic differences in oxidative stress and inflammatory responses to diet-induced obesity do not alter liver fibrosis in mice

21 January 2018

1 reference

Increase in liver antioxidant enzyme activities in non-alcoholic fatty liver disease

21 January 2018

1 reference

c-Jun N-terminal kinase signaling in the pathogenesis of nonalcoholic fatty liver disease: Multiple roles in multiple steps.

21 January 2018

1 reference

Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis

21 January 2018

1 reference

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

21 January 2018

1 reference

Nonalcoholic fatty liver disease: pathology and pathogenesis

21 January 2018

1 reference

Long-term follow-up of patients with NAFLD and elevated liver enzymes

21 January 2018

1 reference

Epidemiology and natural history of non-alcoholic steatohepatitis

21 January 2018

1 reference

Long-term follow-up of patients with nonalcoholic fatty liver

21 January 2018

1 reference

Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.

21 January 2018

1 reference

Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network

21 January 2018

1 reference

Histopathology of pediatric nonalcoholic fatty liver disease.

21 January 2018

1 reference

NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice

21 January 2018

1 reference

Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study

21 January 2018

1 reference

Advances in pediatric nonalcoholic fatty liver disease

21 January 2018

1 reference

Portal inflammation is associated with advanced histological changes in alcoholic and non-alcoholic fatty liver disease

21 January 2018

1 reference

Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease

21 January 2018

1 reference

Non-alcoholic steatohepatitis: from cell biology to clinical practice

21 January 2018

1 reference

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

Histological assessment of non-alcoholic fatty liver disease

21 January 2018

1 reference

Histopathology of nonalcoholic fatty liver disease

21 January 2018

1 reference

Clinicopathological correlations in a series of adult patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

Predictors reflecting the pathological severity of non-alcoholic fatty liver disease: comprehensive study of clinical and immunohistochemical findings in younger Asian patients.

21 January 2018

1 reference

Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity

21 January 2018

1 reference

Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice.

21 January 2018

1 reference

Kupffer cells in non-alcoholic fatty liver disease: the emerging view.

21 January 2018

1 reference

Macrophages: master regulators of inflammation and fibrosis

21 January 2018

1 reference

Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD.

21 January 2018

1 reference

Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens

21 January 2018

1 reference

Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis

21 January 2018

1 reference

The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease?

21 January 2018

1 reference

Kupffer cell and interleukin-12-dependent loss of natural killer T cells in hepatosteatosis

21 January 2018

1 reference

Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease.

21 January 2018

1 reference

Role of IL-17 and Th17 cells in liver diseases

21 January 2018

1 reference

Visceral fat: a key mediator of steatohepatitis in metabolic liver disease.

21 January 2018

1 reference

Adipose tissue macrophages: their role in adipose tissue remodeling

21 January 2018

1 reference

A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents

21 January 2018

1 reference

Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity.

21 January 2018

1 reference

Association of intramyocellular, intraperitoneal and liver fat with glucose tolerance in severely obese adolescents

21 January 2018

1 reference

Adiposity of the heart, revisited

21 January 2018

1 reference

Examination of 'lipotoxicity' in skeletal muscle of high-fat fed and ob/ob mice

21 January 2018

1 reference

Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver

21 January 2018

1 reference

Non-alcoholic steatohepatitis with normal aminotransferase values

21 January 2018

1 reference

Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort

21 January 2018

1 reference

The biology of incretin hormones

21 January 2018

1 reference

Cellular and molecular mechanisms of liver injury

21 January 2018

1 reference

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

21 January 2018

1 reference

Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients

21 January 2018

1 reference

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

21 January 2018

1 reference

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients.

21 January 2018

1 reference

A noninvasive clinical scoring model predicts risk of nonalcoholic steatohepatitis in morbidly obese patients

21 January 2018

1 reference

Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis

21 January 2018

1 reference

JNK1 but not JNK2 promotes the development of steatohepatitis in mice

21 January 2018

1 reference

Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance

21 January 2018

1 reference

How different is the dietary pattern in non-alcoholic steatohepatitis patients?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/EGH.11.21

1 reference

21 June 2017

1 reference